| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/24/1996 | CN1120945A Baishi heat-cleaning granule |
| 04/24/1996 | CN1031620C Pharyngitis buccal tablets and its making method |
| 04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
| 04/23/1996 | US5510254 Three dimensional cell and tissue culture system |
| 04/23/1996 | US5510155 Method to reduce gas transmission |
| 04/23/1996 | US5510122 Collection, then sterilization with chlorhexidine or ionizing radiation, for treating dry mouth disorders |
| 04/23/1996 | US5510113 Promoting hair pigmentation |
| 04/23/1996 | US5510102 Plasma and polymer containing surgical hemostatic adhesives |
| 04/23/1996 | CA1338261C Ws-9326a, ws-9326b and their derivatives |
| 04/21/1996 | CA2160975A1 Use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011014A1 Treatment of bowel-dependent neurological disorders |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996011012A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | WO1996005288A3 T cell activation |
| 04/18/1996 | CA2202472A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706400A1 Therapeutic formulation and method |
| 04/17/1996 | EP0706368A1 Anti-acne composition containing a poria cocos wolf extract |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0368902B1 Method for eradicating infectious contaminants in tissues |
| 04/17/1996 | CN1120803A Method and apparatus for treating a body fluid |
| 04/17/1996 | CN1120585A Live bacteria preparation containing Bacillus subtilis and its application in treatment of burns |
| 04/17/1996 | CN1120439A Low temperature albumin fractionation using sodium caprylates as a partitioning agent |
| 04/16/1996 | US5507810 Processing of fibrous connective tissue |
| 04/16/1996 | CA1338245C Compound dc-107 and process for its preparation |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010584A1 Process for extracting high-purity von willebrand factor |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010427A2 Cellular attachment to trans-epithelial appliances |
| 04/11/1996 | WO1996010420A1 Composition and treatment for hyperimmunization with non heat-killed bacteria |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010410A1 Anti-inflammatory factor, method of isolation, and use |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/10/1996 | EP0705882A2 Blood compatible, shear sensitive formulations |
| 04/10/1996 | EP0705845A2 Process of simultaneous removal of tumor necrosis factor and bacterial lipopolysaccharides from an aqueous solution |
| 04/10/1996 | EP0705604A2 Dermatologic compositions containing a mixture of wool wax acids against superinfections |
| 04/10/1996 | EP0705603A1 Use of non-toxic cysteine sulfoxide derivatives in the treatment of cancer or for enhancing the T-cell count |
| 04/10/1996 | EP0705114A1 Process and apparatus for removal of unwanted fluids from processed blood products |
| 04/10/1996 | EP0705104A1 Method of cancer treatment |
| 04/10/1996 | EP0484438B1 Biological preparation and its use |
| 04/10/1996 | CN1119953A 蚂蚁啤酒 Ants beer |
| 04/10/1996 | CN1119950A Traditional Chinese medicine "Zhenhuang" powder and its production method |
| 04/10/1996 | CN1119944A Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither |
| 04/09/1996 | US5506333 Separating blood by centrifuging |
| 04/09/1996 | US5506127 Therapeutic grade thrombin produced by chromatography |
| 04/09/1996 | US5505980 Mixing with ethanol; freeze drying; heating; grinding |
| 04/09/1996 | US5505955 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 04/09/1996 | US5505908 Adsorbing, desorbing molecular sieve within enclosure, circulation with air |
| 04/09/1996 | US5505685 Automation of plasma sequestration |
| 04/06/1996 | CA2159054A1 Blood compatible, shear sensitive formulations |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 04/04/1996 | WO1996010086A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009832A1 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid |
| 04/04/1996 | WO1996009831A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 04/04/1996 | WO1996009830A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | CA2201395A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 04/04/1996 | CA2200973A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704218A2 Bone reinforcing agent and foods and drinks product containing the same |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0703988A1 Mesothelial cell gene therapy |
| 04/03/1996 | EP0535091B1 Osteoinductive pharmaceutical formulations |
| 04/03/1996 | EP0445280B1 Therapeutic agent and method of inhibiting vascularization of tumors |
| 04/02/1996 | US5504228 From acylation of hydrolysates of silk waste; mainly-glycine, alanine and serine |
| 04/02/1996 | US5503990 Subjecting chopped bovine tracheal cartilage to enzymatic reduction to remove proteins and fat; impact jet milling at cryogenic temperature to attain uniform particle sizing |
| 04/02/1996 | CA2102299C Blood filter and method of filtration |
| 03/28/1996 | WO1996009543A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009395A2 Drug for the prevention and treatment of auto-immune and viral diseases, and diagnostic agents for detecting said diseases |
| 03/28/1996 | WO1996009385A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 03/28/1996 | WO1996009380A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 03/28/1996 | WO1996009376A1 Therapeutic grade thrombin production and products |
| 03/28/1996 | WO1996009374A1 Human galactokinase gene |
| 03/28/1996 | WO1996009373A1 Fibroblasts for the treatment of muscular disorders |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009060A1 Cell growth regulator |
| 03/28/1996 | WO1996009059A1 Improved method and composition for the treatment of ulcers |
| 03/28/1996 | WO1996009042A1 Compositions and methods for the control of smoking |
| 03/28/1996 | WO1996006929A3 Rapid expansion method ('rem') for in vitro propagation of t lymphocytes |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200755A1 Compositions and methods for the control of smoking |
| 03/28/1996 | CA2200724A1 Human galactokinase gene |
| 03/28/1996 | CA2200709A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | CA2198379A1 Fibroblasts for the treatment of muscular disorders |
| 03/27/1996 | EP0702955A1 Drug for AIDS therapy |
| 03/27/1996 | EP0702903A1 Process for producing fat- and cholesterol-reduced egg-based powdery products of high phospholipid content |
| 03/27/1996 | EP0702898A1 A process for the production of alkali-treated powder possessing an immunological activity |